May 20-25, 2012 - Albufeira, Portugal
| Editors: | B. Buckland, University College London, UK |
|---|---|
| J. Aunins, Janis Biologics, LLC | |
| P. Alves , ITQB/IBET | |
| K. Jansen, Wyeth Vaccine Research |
The articles for these proceedings are not peer-reviewed.
Comprehensive T cell antigen discovery using a genomic approach, Jessica Baker (Conference Proceeding)
Rational design of a fully synthetic nanoparticle-based vaccine for smoking cessatio, Takashi Kishimoto (Conference Proceeding)
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms via Erythrocyte-to- Hepatic/Splenic Targeting, Jeffrey Hubbell (Conference Proceeding)
Development of a Vaccine Against Clostridium difficile Infection (CDI): Design, Purification, and Biological Activities of the Recombinant Toxin 1 Antigens, Jerzy Karczewski (Conference Proceeding)
111 years producing immunobiologicals: New challenges, Jorge Kalil (Conference Proceeding)
Bringing Vaccine Manufacturing Capabilities to the Developing World, George Robertson (Conference Proceeding)
Recombinant VLP based human vaccines for emerging markets, Qinjian Zhao (Conference Proceeding)
Establishing human vaccine manufacturing in Southern Africa, Morena Makhoana (Conference Proceeding)
Recombinant influenza vaccine, Manon Cox (Conference Proceeding)
Process understanding approach for a late-stage recombinant protein vaccine produced in Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, and Nedim Altaras (Conference Proceeding)
Challenges in development of an anti-idiotypic cancer vaccine, Adolfo Castillo (Conference Proceeding)
Expectation of China's contribution to world vaccine development and supplies: Status, strategy and international approach, Li Shi (Conference Proceeding)
Rabies virus-like particles expressed in HEK293 cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, and Claudio Prieto (Conference Proceeding)
The role of public-private partnerships in advancing vaccine technologies and improving vaccine effectiveness and delivery for developing countries, Ray Cummings (Conference Proceeding)
Challenges in Batch Production of Malaria Vaccines, Nicolas Havelange (Conference Proceeding)
Formulation and Stability of a Chikungunya Virus-Like Particle (ChikV VLP) Based Vaccine, Rhicard Schwartz (Conference Proceeding)
High throughput formulation design for a stable lyophilized virus-like particle vaccine against Group A Streptococcu, Yap Chuan (Conference Proceeding)
Challenges in Optimizing Formulations for Multi- Antigen Vaccines, Lakshmi Khandke (Conference Proceeding)
A Protein-Free Process and Product Protection System, Stephen Ward (Conference Proceeding)
A new successful vaccine against babesiosis: Any use for malaria?, Thep Schetters (Conference Proceeding)
Leishmaniasis vaccine development: Animals as models and patients, Steven Reid (Conference Proceeding)
Rift valley fever: Next generation vaccines for an old foe, Brian Bird (Conference Proceeding)
Functional genomics as a tool to define a molecular signature of effective vaccination against foot and mouth disease virus, Jose Chabalgoity (Conference Proceeding)
Oncolytic viruses as cancer therapies, Stephen Rusell (Conference Proceeding)
The CMC challenges in Developing an Oncolytic Immunotherapy, Colin Love (Conference Proceeding)
Process Development for a Peptide Conjugated QbetaVirus Like Particle (VLP) Vaccine, Jennifer Thorn (Conference Proceeding)
Chimpanzee ad vector technology platform for prophylactic and therapeutic genetic vaccine applications, Stefano Colloca (Conference Proceeding)
Cervical cancer immunotherapy: Induction of HPV specific CTLs in human volunteers after VGX-3100 immunization, Niranjan Sardesai (Conference Proceeding)
Microbial fermentation: New tools to speed-up vaccine antigen development and increase process knowledge, Catherine Jourdat (Conference Proceeding)
Bacterial expression of a VLP Sub-unit for rapid and cheap influenza vaccination, Anton Middelberg (Conference Proceeding)
High cell density cultivations for influenza virus production using suspension cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, and U. Reichl (Conference Proceeding)
RMCE-based Sf9 cell factory for production of multi-meric VLPs, Ana Teixera (Conference Proceeding)
Systematically Characterizing Adventitious Agent Tests for Biologics, Rebecca Sheets (Conference Proceeding)
Automation and multiplexing of immunoassays: Improving precision and throughput, Ilia Tikhonov (Conference Proceeding)
Developing a Suite of Analytics to Support Process Development for the Manufacture of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, and Tarit Mukhopadhyay (Conference Proceeding)
Building Pandemic Preparedness Through a Sustainable Enterprise for Influenza Vaccines, Robert Huebner (Conference Proceeding)
Bacterium-like particles as delivery vehicles for multimeric antigens, Kees Leenhouts (Conference Proceeding)
Mutiply activated VLP influenza vaccines, James Swartz, Yuan Lu, John Welsh, and Wei Chan (Conference Proceeding)
Endotoxin-free E. Coli hosts for vaccine discovery and production, David Bramhill (Conference Proceeding)
Novel glycoconjugate vaccines based on rationally designed synthetic carbohydrate antigens, Stwewart Campbell (Conference Proceeding)
Utilizing ‘omics tools to investigate the impact of process changes on product quality in cell culture-based influenza vaccine production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, and U. Reichl (Conference Proceeding)
Monolithic Columns for Purification and In-process Control of Viruses and Virus-like Particles, Lidija Urbas and Milos Barut (Conference Proceeding)
Plant-Made Influenza Virus-Like Particles: for Pandemic and Beyond, Nathalie Charland (Conference Proceeding)
Flunisyn: Advanced development of a synthetic universal influenza t-cell vaccine, Campbell Bunce (Conference Proceeding)
Purification of cell-based influenza H5N1 viruses by liquid chromatography technologies, Alan Yung-Chih Hu (Conference Proceeding)
Viral sensitizer technology improves yield of modified vaccinia ankara from available cell substrates, Facrice Le Boeuf (Conference Proceeding)
Suspension Vero cells (sVERO) for poliovirus production: Effect of culture passage on growth kinetics and productivity, Guillermina Forno (Conference Proceeding)
Conference Program, Engineering Conferences International (Conference Proceeding)